FDA inspection
Respirent Pharmaceuticals Co., Ltd.: FDA inspection ending Aug 18, 2023
FDA inspection 1219606 · No Action Indicated (NAI) · Chongqing
Key facts
| Inspection ID | 1219606 |
|---|---|
| Firm | Respirent Pharmaceuticals Co., Ltd. |
| FEI number | 3015685668 |
| Address | 5 Yuntu Road, Beibei |
| City | Chongqing |
| Fiscal year | 2023 |
| Inspection end date | Aug 18, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data